Skip to content
    Compare notes on r/BodyHackGuideCompare notes with other researchers. Join r/BodyHackGuide

    Sermorelin

    Growth Hormone / IGF-1 Axis

    Status
    FDA-approved 1990 and 1997 (Geref)
    Evidence

    Small human trials, approval withdrawn, graded on the CJC-1295 + Ipamorelin GH Secretagogue Bench

    Sermorelin acetate is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of human growth hormone-releasing hormone (GHRH 1-29).

    Reviewed

    01Overview

    What Sermorelin is

    It was one of the first GHRH analogs to achieve FDA approval: Geref Diagnostic in 1990 for evaluating pituitary GH secretion, and Geref in 1997 for idiopathic growth hormone deficiency in children with growth failure. Both approvals were withdrawn effective 18 June 2009. Although the branded product was discontinued commercially in 2008 due to market factors unrelated to safety or efficacy, sermorelin has experienced a significant second life through 503B compounding pharmacies that supply it for off-label use in adult growth hormone axis support, anti-aging medicine, and athletic performance contexts.

    Read the full overviewShow less

    Sermorelin binds the GHRH receptor (GHRHR) on pituitary somatotrophs and triggers endogenous growth hormone release through the body's native negative-feedback architecture. Because it relies on pituitary reserve rather than bypassing it, sermorelin produces pulsatile GH release that respects somatostatin inhibition — you cannot overshoot the way exogenous recombinant human GH can, and IGF-1 typically rises into the upper quartile of age-adjusted normal rather than into supraphysiological territory. This is the fundamental mechanistic difference that makes GHRH therapy tolerable for long-term use where rhGH use carries more concerning risks.

    Its short serum half-life — approximately 10 to 20 minutes in healthy adults — is simultaneously sermorelin's greatest limitation and its most clinically elegant feature. The short window forces once-daily bedtime dosing that aligns with the body's natural nocturnal GH pulse, and it means residual peptide never persists long enough to disturb subsequent endogenous pulses. Modern practitioners frequently choose sermorelin over longer-acting analogs like CJC-1295 DAC specifically because the pulsatile kinetics more closely mimic healthy young physiology.

    In research and clinical settings, sermorelin is typically dosed at 200 to 500 mcg subcutaneously at bedtime for adult GH tuning protocols, though historical pediatric GHD protocols used up to 30 mcg/kg/day. Controlled trials in healthy older adults found modest gains in lean body mass in men, a rise in IGF-1 in both sexes, and no change in sleep quality. Bedtime dosing lines up with the natural nocturnal GH pulse, which is when most physiologic GH secretion occurs.

    How it works

    GHRH Receptor Pharmacology

    Sermorelin is a truncated analog - the first 29 amino acids - of the 44-amino-acid native GHRH produced by the arcuate nucleus of the hypothalamus. The 1-29 fragment retains essentially the full growth-hormone-releasing activity of the parent hormone; the C-terminal residues 30-44 contribute to stability but are not required for receptor binding or activation [PMID:8772599].

    Read the full mechanismShow less

    When sermorelin binds the GHRH receptor (GHRHR) - a class B G-protein-coupled receptor expressed on anterior-pituitary somatotrophs - it triggers:

    • Gs-protein activation increased cyclic AMP protein kinase A signaling
    • Transcription of the GH1 gene and exocytosis of stored GH secretory granules
    • Synergy with the ghrelin/GHS-R1a pathway when a growth-hormone secretagogue (e.g., ipamorelin) is co-administered

    The net effect is a pulsatile release of the body's own growth hormone rather than the flat, supraphysiologic exposure produced by injecting recombinant HGH, which bypasses the pituitary entirely.

    Pulsatility and the Somatostatin Gate

    GHRH-driven GH release remains subject to somatostatin tone. Somatostatin - released from the periventricular nucleus of the hypothalamus - sets a ceiling on how much GH any single GHRH pulse can elicit. This is why sermorelin cannot drive GH to the supraphysiologic levels achievable with exogenous HGH, and why it preserves the natural ultradian rhythm of GH secretion. Dose-response work in older men showed GH and IGF-1 output rise with dose and then plateau, consistent with this somatostatin ceiling [PMID:1379256].

    Short Half-Life as a Feature

    Native GHRH has a plasma half-life of roughly 7 minutes; sermorelin clears with a half-life on the order of 10-20 minutes. This rapid clearance:

    1. Limits receptor desensitization that continuous GHRH exposure would cause
    2. Allows somatostatin pulses to suppress GH between cycles
    3. Reproduces the brief GHRH pulses that occur naturally in young adults

    This is also why sermorelin must be dosed daily, whereas long-acting analogs such as CJC-1295-DAC extend the dosing interval but sacrifice the pulsatile pharmacology.

    Downstream Effects

    Nightly sermorelin (or the closely related GHRH(1-29) analogs used in trials) raises IGF-1 within the physiologic range rather than above it. In the main controlled adult trial, IGF-1 rose ~28% and skin thickness increased in both sexes, while lean-body-mass, insulin-sensitivity, general well-being and libido improvements were seen in men only [PMID:9141536][PMID:9360512]. Effects reported across the literature (with varying strength of evidence) include:

    • Modest lean-mass gains and small reductions in body fat (male-predominant in the controlled data)
    • A tendency toward improved slow-wave (NREM) sleep - GHRH is itself a sleep-regulatory peptide, and the largest physiologic GH pulse occurs during early slow-wave sleep
    • Subjective improvements in recovery and skin quality

    These should be read as physiologic restoration toward a more youthful GH secretion pattern - not the supraphysiologic anabolism of recombinant HGH or anabolic steroids. Notably, single-nightly dosing produced no measurable IGF-1 or body-composition change in one 6-week trial [PMID:9005976], so real-world response is variable and dosing schedule matters.

    Studied for

    • Growth hormone deficiency
    • Anti-aging
    • Body composition
    • Pituitary function

    Benefits listed

    • Natural GH pulse stimulation
    • Better sleep reported by users, unchanged in trials
    • Enhanced recovery and body composition
    • Anti-aging effects
    Show 2 moreShow less
    • Better skin elasticity
    • Increased lean muscle mass

    02Research

    Free with email

    What the research shows

    Graded on a research bench

    Reference pages that put Sermorelin next to the compounds people pair it with: roles, evidence, overlap and conflicts. No dosing. Research use only.

    Unlock the research summary

    Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.

    • A summary of the key research
    • Safety and side effects
    • A link to the PubMed results

    You also get the free peptide cheat sheet by email. Unsubscribe anytime.

    Have an account? Sign in

    03Safety

    Sermorelin side effects and interactions

    Side effects

    Low risk

    Stop use if

    • Active malignancy
    • Hypothyroidism (treat first)
    • Pituitary tumor

    Common

    • Injection site redness/swelling
    • Headache
    • Flushing
    • Nausea

    Less common

    • Hyperactivity
    • Dizziness
    • Pallor

    Who should not use it

    Contraindications

    Sermorelin is contraindicated or requires extreme caution in:

    • Active malignancy — particularly any hormone-responsive cancer (breast, prostate, endometrial) given the theoretical concern that elevated IGF-1 could promote tumor growth
    • Strong family history of GH-axis responsive cancers — use only under specialist supervision with close monitoring
    • Pregnancy and lactation — no established safety data; avoid
    • Known hypersensitivity to sermorelin, GHRH analogs, or any excipient
    • Severe untreated sleep apnea — theoretical concern about upper airway soft tissue growth; stabilize with CPAP/APAP before initiating
    • Acute critical illness — GH-axis stimulation is inappropriate during sepsis, post-surgical recovery, multiple trauma, or respiratory failure states
    • Diabetic ketoacidosis or severe uncontrolled diabetes — resolve the metabolic state first
    • Active proliferative retinopathy — relative contraindication; discuss with ophthalmologist
    Read all the contraindications and cautionsShow less

    Relative cautions requiring monitoring:

    • Borderline fasting glucose or HbA1c — monitor closely; discontinue if deterioration
    • History of benign adenomas (pituitary, adrenal, thyroid) — imaging surveillance recommended
    • Strong family history of colon polyps — baseline colonoscopy before starting, surveillance per gastroenterology guidance
    • Concurrent glucocorticoid therapy — pharmacodynamic interference; GH-axis stimulation is less effective in pharmacologic steroid contexts

    Age-related note: Sermorelin has been used in pediatric GHD populations historically with FDA approval, but use in healthy older adults for anti-aging purposes remains off-label and should only be undertaken with informed consent about the limitations of available long-term safety data.

    Interactions

    5 pairings in our record: 1 to avoid, 1 with a caution and 3 noted as compatible or synergistic. Compatible and synergistic are notes from the record, not safety findings.

    • Tesamorelin

      Avoid

      Both GHRH analogs — do not combine

    • CJC-1295

      Caution

      Both are GHRH analogs — redundant mechanisms

    • Ipamorelin

      Synergistic

      GHRH + GHRP for amplified natural GH pulses

    • GHRP-2

      Synergistic

      Classic GHRH + GHRP combination

    • MK-677

      Compatible

      Can add oral GHS for daytime support alongside evening sermorelin

    This interaction data is compiled from published research and community reports. It may not be exhaustive. Always consult a healthcare professional before combining compounds.

    Need bloodwork before starting?

    Full hormone + metabolic panels from Anabolic Insights. Code CHONCH for first-order discount.

    Order Bloodwork

    04Dosing

    Free with email

    Sermorelin dosage and protocols

    Unlock the dosing protocols

    Enter your email to keep reading. It is free, and it opens these sections on every compound page in this browser.

    • Dose, route, how often and how long
    • A titration schedule
    • Beginner, intermediate and advanced protocols
    • Reconstitution and handling notes

    You also get the free peptide cheat sheet by email. Unsubscribe anytime.

    Have an account? Sign in

    05Prices

    Sermorelin prices

    8 listings from 4 vendors, opening in the Featured order.

    Pack prices
    $24.99 to $65.00
    Lowest per mg
    $6.50/mg
    Vendors
    4
    Listings
    8 (vial)

    Prices as the vendors list them, last recorded 8 October 2026.

    Size
    Form
    Sort
    Sermorelin listings, in Featured order
    VendorProductPriceBuy

    Sermorelin Acetate

    vial, 1 vial

    In stock

    $49.99

    No mg count

    Buy Sermorelin Acetate at Disguised Alpha

    Sermorelin 5mg

    vial, 1 vial

    Out of stock

    $7.80/mg

    $39.00

    View Sermorelin 5mg at Ion Peptide

    Sermorelin 10mg

    vial, 1 vial

    In stock

    $6.50/mg

    $65.00

    Lowest per mg
    Buy Sermorelin 10mg at Ion Peptide

    Sermorelin 15mg

    vial, 1 vial

    Out of stock

    $5.67/mg

    $85.00

    View Sermorelin 15mg at Ion Peptide

    Sermorelin 5mg

    vial, 1 vial

    In stock

    $7.00/mg

    $34.99

    Buy Sermorelin 5mg at BioMyst Labs

    Sermorelin 5mg

    vial, 1 vial

    In stock

    $8.00/mg

    $39.99

    Buy Sermorelin 5mg at BioMyst Labs

    Sermorelin 2mg

    vial, 2mg vial

    In stock

    $12.49/mg

    $24.99

    Buy Sermorelin 2mg at Half Nattys

    Sermorelin 5mg

    vial, 5mg vial

    In stock

    $8.00/mg

    $39.99

    Buy Sermorelin 5mg at Half Nattys
    Vendors selling Sermorelin(4: trust score, certificates, payment, shipping)

    Every supplier above is graded 0 to 100 on COA verification, payment transparency, shipping, reviews, and active listings. Methodology published, no pay-to-rank. How we score these vendors

    Price history(4 days with a recorded price)
    Review Sermorelin

    Sign in to leave a review

    Reviews on BodyHackGuide are tied to verified user accounts and moderated before publishing. Sign in (free, no spam) to share your experience with Sermorelin.

    06Chemistry

    Chemistry and structure

    Molecular formula
    C149H246N44O42S
    Molecular mass
    3357.9 g/mol
    CAS number
    86168-78-7
    IUPAC name
    Growth hormone-releasing hormone (1-29) amide
    Amino acid sequence
    YADAIFTNSYRKVLGQLSARKLLQDIMSR-NH2 (29 residues; GHRH(1-29) with a C-terminal amide). Full sequence: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. Molecular formula C149H246N44O42S; molecular weight ~3357.9 g/mol.
    Half-life
    ~10-20 minutes (plasma; native GHRH 7 minutes)
    View on PubChem

    08Questions

    Frequently asked questions

    What is sermorelin and how does it work?

    Sermorelin is a synthetic 29-amino-acid peptide corresponding to the biologically active N-terminal fragment of GHRH - the hypothalamic hormone that tells your pituitary to release growth hormone. It binds the GHRH receptor on pituitary somatotrophs, triggering a pulsatile release of endogenous GH that respects the body's natural negative feedback architecture. It was approved as Geref Diagnostic in 1990 for evaluating pituitary GH secretion and as Geref in 1997 for pediatric growth hormone deficiency; both approvals were withdrawn effective 18 June 2009, and it is now used off-label through 503B compounding pharmacies for adult GH optimization. Unlike recombinant HGH, sermorelin cannot produce supraphysiologic GH levels because somatostatin limits how much GH any single GHRH pulse can elicit.

    How is sermorelin different from CJC-1295?

    Sermorelin is pure GHRH(1-29) with a 10-20 minute half-life. CJC-1295 without DAC is a stabilized GHRH analog with a modestly longer half-life (~30 minutes), and CJC-1295 DAC adds a DAC linker that extends half-life to ~8 days. Sermorelin and no-DAC CJC-1295 produce pulsatile GH release; CJC-1295 DAC produces continuous GHRH-receptor stimulation that raises baseline GH and IGF-1 more dramatically but eliminates pulsatility. For users prioritizing the most physiologic secretion pattern and minimum receptor desensitization risk, sermorelin is the most conservative choice. For users prioritizing convenience (once or twice weekly dosing), CJC-1295 DAC wins. See the CJC-1295 page for a detailed side-by-side.

    What results should I expect from sermorelin?

    Be realistic - the controlled human data are modest. In the main adult trial of GHRH(1-29) (Khorram 1997), IGF-1 rose about 28% and skin thickness increased in both sexes, but lean body mass and quality-of-life gains appeared in men only, and a separate 6-week trial of single nightly dosing found no IGF-1 or body-composition change at all. So expect a modest IGF-1 rise into the upper-normal range, possibly small improvements in body composition, recovery, sleep depth and skin quality over 12-16 weeks, and nothing resembling recombinant HGH or anabolic steroids. Sermorelin is best understood as nudging your own GH secretion back toward a more youthful pattern rather than delivering supraphysiologic GH. Individual response varies widely.

    What is the best sermorelin dosage?

    The typical adult protocol is 200-500 mcg subcutaneously once nightly at bedtime. Beginners start at 200-300 mcg to assess tolerance. After 6-12 weeks, responders typically titrate to 300-500 mcg based on IGF-1 response. The single-dose ceiling is around 500 mcg - above that, somatostatin tone prevents further GH release, so higher doses are simply wasted peptide. Some advanced users split the dose into a morning and evening injection, though the bedtime-only approach remains the most common and best-studied. Always dose in a fasted state (3+ hours after last meal) to avoid the insulin-driven somatostatin surge that would blunt GH release.

    Can I stack sermorelin with ipamorelin?

    Yes - sermorelin + ipamorelin is the classic and most well-established GHRH + GHS combination in the peptide space. The two compounds bind different receptors on the same pituitary somatotrophs (GHRHR and GHS-R1a respectively) and produce a 3-5x amplification of GH pulse amplitude compared to either compound alone (Bowers 1991). Typical stack dose is sermorelin 200-300 mcg + ipamorelin 200-300 mcg in the same subcutaneous injection at bedtime. Ipamorelin's selectivity - it does not elevate cortisol, prolactin, or ACTH - makes it the cleanest ghrelin mimetic to pair with sermorelin. See ipamorelin for full details.

    Is sermorelin still FDA approved?

    Sermorelin acetate received FDA approval as Geref Diagnostic in 1990 for evaluating pituitary GH secretion and as Geref in 1997 for pediatric growth hormone deficiency. Both products were discontinued in 2008 for commercial reasons, not safety or efficacy, and FDA withdrew both approvals effective 18 June 2009, so no FDA-approved sermorelin product is marketed today. The peptide itself remains legally available through 503B compounding pharmacies that produce it for physicians who prescribe it off-label for adult GH optimization. This legal-but-compounded status is similar to many other legacy peptides. Clinical use is supervised by medical professionals, and the quality-controlled compounded version is considered equivalent to the original Geref for pharmacologic purposes.

    How long does it take sermorelin to work?

    The GH and IGF-1 response to a single sermorelin injection occurs within minutes - peak serum GH typically occurs 15-30 minutes post-injection. However, the clinically meaningful body composition and subjective effects take 6-16 weeks of consistent nightly dosing to become apparent. IGF-1 stabilizes at its new elevated setpoint around week 4-6. Lean body mass changes are detectable by week 8-12. Reports of better sleep often show up earliest, within 2-3 weeks, but these are user reports: the controlled trial of GHRH(1-29) found sleep quality unchanged. Skin changes (improved thickness, hydration) take 12-16 weeks to measure but are usually subjectively noticed earlier.

    What are the side effects of sermorelin?

    Most side effects are mild and transient. The most common are injection site reactions (erythema, mild itching), facial flushing immediately after injection (fades within 10-20 minutes), and occasionally vivid dreams - which isn't necessarily adverse, though the controlled trial of GHRH(1-29) found sleep quality unchanged. Less common effects include mild headache, transient hunger (less pronounced than with ghrelin mimetics), and minor fluid retention in the first weeks. Theoretical long-term concerns relate to sustained IGF-1 elevation and cancer risk, though no causal link has been demonstrated in trials to date. Stop if you develop persistent joint pain, carpal tunnel symptoms, or peripheral edema - these suggest IGF-1 is too high.

    Does sermorelin cause weight loss?

    Sermorelin is not primarily a weight-loss compound. It produces modest reductions in visceral and subcutaneous fat over 12-16 weeks - typically 1-3% body fat in responders - alongside lean mass gains of similar magnitude. Users looking for dramatic weight loss should consider GLP-1 receptor agonists like semaglutide, tirzepatide, or retatrutide. Sermorelin is better understood as a body-composition-optimization tool that modestly improves the fat-to-lean ratio rather than a fat-loss drug. If visceral adiposity specifically is the target, tesamorelin has FDA-approved trial data showing roughly 18% VAT reduction over 26 weeks, which is substantially more aggressive than sermorelin achieves.

    Where can I buy sermorelin legally?

    In the United States, sermorelin can be prescribed legally by licensed physicians and dispensed through 503B compounding pharmacies. This is the proper legal pathway - the prescribing physician oversees dosing, labs, and safety monitoring. There is also a gray-market research-chemical supply chain outside of medical oversight, but this path carries significant quality-control, sterility, and legal risk. Prescribed compounded sermorelin through a qualified clinic is the only path we recommend. For a curated list of peptide-friendly clinical practices and reliable compounded-peptide pharmacies, see our best vendors guide for 2026.

    How many vendors sell Sermorelin, and what does it cost per mg?

    4 of the vendors BodyHackGuide tracks list Sermorelin (8 listings). Among BodyHackGuide's Sermorelin listings recorded as in stock with a milligram count, the lowest price per milligram is $6.50/mg at Ion Peptide and the median is $8.00/mg. The Sermorelin prices on BodyHackGuide are vendors' listed prices as BodyHackGuide last recorded them, not transactions; the most recent recorded change to a Sermorelin listing is dated 8 October 2026.

    Which vendors have third-party COAs for Sermorelin on file at BodyHackGuide?

    BodyHackGuide holds 79 third-party certificate records for Sermorelin, from . No editor has read any of BodyHackGuide's 79 certificate records for Sermorelin. The laboratory named on BodyHackGuide's Sermorelin certificate records is Freedom Diagnostics Testing, and the newest test date on them is 6 October 2026. Each vendor page on BodyHackGuide shows how many certificate records BodyHackGuide holds for that vendor and links to each record that has its own page.

    Related

    Articles on Sermorelin

    Free 2026 Peptide Cheat Sheet (PDF)

    38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers.

    Download Free